Steven Holm

Associate
sholm@cooley.com
Full contact info

I partner with founders, management teams and investors to provide practical and straight-forward guidance through all stages of growth.

About Steven

Steven focuses his practice on advising both public and private companies and investors across South and Southeast Asia on strategic transactions and corporate governance.

Steven is counsel to companies across a broad range of industries and ranging from start-ups to well established companies. He is passionate about the “bits & atoms” Life Sciences, AgTech, DeepTech and CleanTech ecosystem in Southeast Asia and diversifying the new economy ecosystem.

 

 

View full bio

Passions

Travel

Cycling

Street Food

Experience

Hummingbird Bioscience Announces Exclusive Worldwide License Agreement With Callio Therapeutics

Hummingbird Bioscience Announces Exclusive Worldwide License Agreement With Callio Therapeutics

March 3, 2025

Cooley advised Hummingbird Bioscience, a Singapore-based biotherapeutics company working at the interface of artificial intelligence and human innovation to discover and develop transformative medicines for hard-to-treat diseases, on its exclusive worldwide license agreement with Callio Therapeutics, a newly launched biotech company focused on realizing the promise of multipayload antibody-drug conjugates (ADCs) to improve cancer therapy.

Read more

Related contacts

James Schneider
Partner, Boston
Jeffrey J. Tolin
Partner, New York
Steven Holm
Associate, Singapore
Michael Fernando
Associate, London
Michael Bergmann
Partner, Washington, DC
Paula Holland
Partner, London
Nicola Squire
Partner, London
Yi Jia Ng
Special Counsel, Singapore
Bethan Chalmers
Associate, London
Gwenlynne Lee
Counsel, Singapore
Amanda Pacheco
Associate, Palo Alto
Alexandra Paterson
Associate, London
Mara Rosario
Associate, Boston
Arda Can Tekin
Associate, New York

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Emerging Companies
Capital Markets
Tax
Compensation and Benefits

Cooley Advises Life360 on $178.5 Million IPO

Cooley Advises Life360 on $178.5 Million IPO

June 7, 2024

Cooley advised Life360, a family connection and safety company, on its $178.5 million initial public offering.

Read more

Related contacts

C. Thomas Hopkins
Partner, Santa Monica
David Peinsipp
Partner, San Francisco
Siana Lowrey
Of Counsel
Alexander Gefter
Associate, Santa Monica
Jaleel Chandler
Associate, Santa Monica
Baasit Bhutta
Associate, Colorado
Michael Aridi Barake
Associate, Santa Monica
Grady Chang
Associate, Santa Monica
Steven Holm
Associate, Singapore
Valerie Sapozhnikova
Associate, Los Angeles
Samara Zaifman
Associate, Palo Alto
Ryan Lewis
Associate, Colorado
Alanna Anderson
Associate, Palo Alto
Krina Desai
Associate, Palo Alto
Kristine Kevorkova
Associate, Santa Monica
Reid Hooper
Special Counsel, Washington, DC
Justin Kisner
Special Counsel, Palo Alto
Alessandra Murata
Partner, Palo Alto
Travis LeBlanc
Partner, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Mari Dugas
Associate, Washington, DC
Todd Gluth
Partner, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Rick Jantz
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Mischi a Marca
Partner, San Francisco
Brian Youn
Paralegal Specialist, Palo Alto
Melanie Yuvienco
Paralegal Specialist, Palo Alto

Related Practices & Industries

Capital Markets
Cyber/Data/Privacy
Public Companies
Compensation and Benefits
Private Equity

Summit Healthcare Closes Business Combination With YS Biopharma

Summit Healthcare Closes Business Combination With YS Biopharma

March 20, 2023

Cooley advised Summit Healthcare Acquisition Corp. (Summit Healthcare), a publicly traded special purpose acquisition company, on its business combination with YishengBio Co., Ltd. (YS Biopharma), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of innovative vaccines and therapeutic biologics.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Tim Pitrelli
Partner, Singapore
Steven Holm
Associate, Singapore
Hilda Li
Associate, Hong Kong
Harvey Yao
Associate, Hong Kong
Samantha Zhang
Associate, Shanghai
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Santa Monica
Calvin Lee
Associate, New York

Admissions and credentials

New York